Phase 3 data on sunvozertinib for EGFR exon 20 insertions and sacituzumab tirumotecan plus pembrolizumab for PD-L1-positive ...

Treatment with anifrolumab (Saphnelo) was associated with numerically higher improvements than placebo in multiple disease-activity measures, supporting the rationale for targeting the type 1 ...

In men, high adolescent cardiorespiratory fitness is linked to a small excess risk for atrial fibrillation in early adulthood ...

England saw its sharpest fall in STI diagnoses in years in 2025, though syphilis trends in women are moving in the wrong ...

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically ...

Researchers used Cox proportional hazard models to compare the risk for natural menopause and linear regression models to ...

As real-world studies show high rates of GLP-1 discontinuation and rapid weight regain, new interventions may help patients ...

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher ...

Discordance between continuous glucose monitoring measures and A1c should not always be interpreted as measurement errors, ...

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Functional neurologic disorder has a higher mortality rate than multiple sclerosis and often occurs with comorbid neurologic ...

Low-dose ICS remain essential for every asthma patient, and GINA/CFA guidance favors phenotype-tailored step-up strategies ...